Header Logo

Connection

Dongfeng Qu to Binding Sites

Back to Details
This is a "connection" page, showing publications Dongfeng Qu has written about Binding Sites.
Dongfeng Qu
Connection Strength
0.027
Binding Sites
  1. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1. Mol Cancer. 2014 May 06; 13:103.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.